Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

ORKA

Oruka Therapeutics Inc

May 29 • 04:00PM ET

58.53

+0.55 0.95 %

Healthcare • Biotechnology • USA • Mid • NASD

Peers: KRYS RYTM BMRN VKTX INCY AXSM MDGL ALNY KROS NBIX

| Held by: VTI IWM XBI VXF IWN IBB VTWO SCHA IWC VHT

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-2.39	Insider Own	15.85%	Shs Outstand	60.31M	Perf Week	-0.27%
Market Cap	3.53B	Forward P/E	-	EPS next Y	-2.49	Insider Trans	-1.89%	Shs Float	50.75M	Perf Month	-14.05%
Enterprise Value	3.15B	PEG	-	EPS next Q	-0.51	Inst Own	76.51%	Short Float	12.32%	Perf Quarter	70.10%
Income	-116.25M	P/S	-	EPS this Y	-14.11%	Inst Trans	-1.89%	Short Ratio	4.29	Perf Half Y	91.78%
Sales	0.00M	P/B	6.07	EPS next Y	-18.03%	ROA	-26.37%	Short Interest	6.25M	Perf YTD	93.10%
Book/sh	9.64	P/C	9.08	EPS next 5Y	-22.30%	ROE	-27.31%	52W High	91.00 -35.68%	Perf Year	393.92%
Cash/sh	6.45	P/FCF	-	EPS past 3/5Y	34.61% 37.79%	ROIC	-23.83%	52W Low	10.64 450.35%	Perf 3Y	336.01%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	4.68% 5.89%	Perf 5Y	159.86%
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	54.61%	Oper. Margin	-	ATR (14)	3.81	Perf 10Y	-84.96%
Dividend Ex-Date	-	Quick Ratio	23.76	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	44.62	Recom	1.07
Dividend Gr. 3/5Y	- -	Current Ratio	23.76	EPS Q/Q	-14.47%	SMA20	-5.99%	Beta	-0.24	Target Price	141.31
Payout	-	Debt/Eq	0.00	Sales Q/Q	-	SMA50	-2.44%	Rel Volume	0.84	Prev Close	57.98
Employees	68	LT Debt/Eq	0.00	Earnings	May 13 AMC	SMA200	66.12%	Avg Volume	1.46M	Price	58.53
IPO	Aug 08, 1997	Option/Short	Yes / Yes	EPS/Sales Surpr.	12.23% -	Trades		Volume	1,228,164	Change	0.95%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)